SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits

By sjmartinez • October 11, 2022

Dixit NM, Ziaeian B, Fonarow GC. SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits. Heart Fail Clin. 2022 Oct;18(4):587-596. doi: 10.1016/j.hfc.2022.03.003. PMID: 36216488.

Tags: Cardiology/Epi, Guideline-directed medical therapy, Heart failure with preserved ejection fraction, Heart failure with reduced ejection fraction, Initiation and sequencing, Publications

A deep learning phenome wide association study of the electrocardiogram

Hughes JW, Theurer J, Vukadinovic M, Rogers AJ, Somani S, Kang G, Ghazizadeh Z, O'Sullivan JW, Jain SS, Gomes B, Salerno M, Ashley E, Zou[...]

Novel insights into post-myocardial infarction cardiac remodeling through algorithmic detection of cell-type composition shifts

Gural B, Kirkland L, Hockett A, Sandroni P, Zhang J, Rosa-Garrido M, Swift SK, Chapski DJ, Flinn MA, O'Meara CC, Vondriska TM, Patterson M, Jensen[...]

The accumulation of progerin underlies the loss of aortic smooth muscle cells in Hutchinson-Gilford progeria syndrome

Kim PH, Kim JR, Heizer PJ, Jung H, Tu Y, Presnell A, Scheithauer J, Yu RG, Young SG, Fong LG. The accumulation of progerin underlies[...]